The pASCs treated with OM + BMP-2 and co-incubated with both SB431542 and dorsomorphin surprisingly showed positive osteogenic differentiation with a similar course in quality as those without inhibitors (Figure 4A, Table S3). This evidence concerns the gene BMP2 and ocular melanoma.